» Articles » PMID: 18578666

Renal Injury and the Application of Polysaccharide Hemospheres: a Laparoscopic Experimental Model

Overview
Journal J Endourol
Publisher Mary Ann Liebert
Date 2008 Jun 27
PMID 18578666
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Microporous polysaccharide hemospheres (MPH) are hemostatic beads engineered from purified plant starch. MPH accelerates the natural clotting cascade by concentrating clotting factors and proteins on their surface while absorbing aqueous and low molecular weight components from blood. The purpose of this study was to determine the efficacy of MPH in achieving hemostasis in the setting of laparoscopic renal injury.

Materials And Methods: In four domestic pigs, 16 laparoscopic renal trocar injuries were created (8 each of 12 and 5 mm). A standard hand-assisted laparoscopic approach was used to each kidney so that two lesions per kidney were randomly created. MPH was applied to each treatment lesion with light pressure maintained for 60 seconds. Four of the 16 lesions, two each of 12 and 5 mm, were allowed to bleed as controls. Hemostasis was defined as no active bleeding or oozing. The animals were sacrificed at the conclusion of the procedure.

Results: The mean time to hemostasis for the 12-mm MPH and control lesions was 196.2 +/- 53.3 and 372.0 +/- 225.6 seconds, while the average blood loss was 8.3 +/- 3.7 and 12.0 +/- 4.9 g, respectively. For the 5-mm MPH and control lesions, the average time to hemostasis was 100.2 +/- 24.8 and 247.0 +/- 134.4 seconds, while the average blood loss was 8.3 +/- 3.8 and 9.0 +/- 0.7 g, respectively. The median number of applications of the MPH for the 5- and 12-mm injuries was 1 and 2, respectively.

Conclusions: MPH provided a rapid and effective means of hemostasis for laparoscopic renal parenchymal injuries in this model. Additional evaluation is warranted, however, before general application is advisable.

Citing Articles

Review of Evidence Supporting the Arista™ Absorbable Powder Hemostat.

LyBarger K Med Devices (Auckl). 2024; 17:173-188.

PMID: 38800552 PMC: 11127658. DOI: 10.2147/MDER.S442944.


Recent Advances on Synthetic and Polysaccharide Adhesives for Biological Hemostatic Applications.

Li D, Chen J, Wang X, Zhang M, Li C, Zhou J Front Bioeng Biotechnol. 2020; 8:926.

PMID: 32923431 PMC: 7456874. DOI: 10.3389/fbioe.2020.00926.


Evaluation of local hemostatic effect of microporous polysaccharide hemospheres products in thyroid surgery: a prospective randomized controlled study.

Kunduz E, Aysan E, Idiz U, Ersoy Y, Bektasoglu H, Yigman S Turk J Surg. 2020; 35(1):49-53.

PMID: 32550303 PMC: 6791685. DOI: 10.5578/turkjsurg.4162.


Comparison of microporous polysaccharide hemospheres and Ankaferd Blood Stopper in a rabbit epistaxis model.

Yurttas V, Sereflican M, Terzi E, Ozyalvacli G, Kazaz H Eur Arch Otorhinolaryngol. 2015; 273(4):933-8.

PMID: 26100031 DOI: 10.1007/s00405-015-3692-8.


Athermal nerve sparing robot-assisted radical prostatectomy: initial experience with microporous polysaccharide hemospheres as a topical hemostatic agent.

Nunez-Nateras R, Hurd K, Ferrigni E, Castle E, Andrews P, Humphreys M World J Urol. 2011; 31(3):523-7.

PMID: 22198725 DOI: 10.1007/s00345-011-0815-8.

References
1.
TUTHILL D, Bayer V, Gallagher A, Drohan W, MacPhee M . Assessment of topical hemostats in a renal hemorrhage model in heparinized rats. J Surg Res. 2001; 95(2):126-32. DOI: 10.1006/jsre.2000.6027. View

2.
Klingler C, Remzi M, Marberger M, Janetschek G . Haemostasis in laparoscopy. Eur Urol. 2006; 50(5):948-56. DOI: 10.1016/j.eururo.2006.01.058. View

3.
Fahlenkamp D, Rassweiler J, Fornara P, Frede T, Loening S . Complications of laparoscopic procedures in urology: experience with 2,407 procedures at 4 German centers. J Urol. 1999; 162(3 Pt 1):765-70; discussion 770-1. DOI: 10.1097/00005392-199909010-00038. View

4.
Murat F, Ereth M, Dong Y, Piedra M, Gettman M . Evaluation of microporous polysaccharide hemospheres as a novel hemostatic agent in open partial nephrectomy: favorable experimental results in the porcine model. J Urol. 2004; 172(3):1119-22. DOI: 10.1097/01.ju.0000136001.99920.97. View

5.
Hong Y, Loughlin K . The use of hemostatic agents and sealants in urology. J Urol. 2006; 176(6 Pt 1):2367-74. DOI: 10.1016/j.juro.2006.07.128. View